United Therapeutics Corp. (UTHR)
515.46
-12.45
(-2.36%)
USD |
NASDAQ |
Aug 28, 16:00
515.31
-0.15
(-0.03%)
After-Hours: 20:00
United Therapeutics Cash and Short Term Investments (Quarterly) : 2.662B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.662B |
| March 31, 2026 | 2.154B |
| December 31, 2025 | 2.920B |
| September 30, 2025 | 2.768B |
| June 30, 2025 | 3.049B |
| March 31, 2025 | 3.321B |
| December 31, 2024 | 3.267B |
| September 30, 2024 | 3.326B |
| June 30, 2024 | 2.972B |
| March 31, 2024 | 2.708B |
| December 31, 2023 | 2.994B |
| September 30, 2023 | 2.876B |
| June 30, 2023 | 2.679B |
| March 31, 2023 | 2.863B |
| December 31, 2022 | 2.839B |
| September 30, 2022 | 2.616B |
| June 30, 2022 | 2.255B |
| March 31, 2022 | 2.268B |
| December 31, 2021 | 1.931B |
| September 30, 2021 | 2.000B |
| June 30, 2021 | 1.968B |
| March 31, 2021 | 1.731B |
| December 31, 2020 | 1.835B |
| September 30, 2020 | 1.580B |
| June 30, 2020 | 1.561B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.544B |
| December 31, 2019 | 1.486B |
| September 30, 2019 | 1.57B |
| June 30, 2019 | 1.786B |
| March 31, 2019 | 1.605B |
| December 31, 2018 | 1.416B |
| September 30, 2018 | 1.238B |
| June 30, 2018 | 1.213B |
| March 31, 2018 | 1.257B |
| December 31, 2017 | 927.40M |
| September 30, 2017 | 1.211B |
| June 30, 2017 | 1.115B |
| March 31, 2017 | 1.156B |
| December 31, 2016 | 1.051B |
| September 30, 2016 | 1.033B |
| June 30, 2016 | 944.70M |
| March 31, 2016 | 975.10M |
| December 31, 2015 | 953.77M |
| September 30, 2015 | 921.84M |
| June 30, 2015 | 440.13M |
| March 31, 2015 | 656.86M |
| December 31, 2014 | 695.54M |
| September 30, 2014 | 767.66M |
| June 30, 2014 | 567.58M |
| March 31, 2014 | 760.49M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Liquidia Corp. | 284.18M |
| MannKind Corp. | 111.13M |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Savara, Inc. | 173.03M |
| Exelixis, Inc. | 839.38M |